Global Buerger Disease Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Buerger Disease Diagnosis market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Buerger's disease is a rare disease of the arteries and veins in the arms and legs. It is also called as thromboangiitis obliterans. In Buerger's disease, the blood vessels become inflamed, swell, and get blocked due to blood clots.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Buerger Disease Diagnosis industry chain, the market status of Hospitals (Blood Tests, The Allen’s Test), Clinics (Blood Tests, The Allen’s Test), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Buerger Disease Diagnosis.

Regionally, the report analyzes the Buerger Disease Diagnosis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Buerger Disease Diagnosis market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Buerger Disease Diagnosis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Buerger Disease Diagnosis industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Tests, The Allen’s Test).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Buerger Disease Diagnosis market.

Regional Analysis: The report involves examining the Buerger Disease Diagnosis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Buerger Disease Diagnosis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Buerger Disease Diagnosis:
Company Analysis: Report covers individual Buerger Disease Diagnosis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Buerger Disease Diagnosis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Buerger Disease Diagnosis. It assesses the current state, advancements, and potential future developments in Buerger Disease Diagnosis areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Buerger Disease Diagnosis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Buerger Disease Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Blood Tests
    The Allen’s Test
    Angiogram
    Tissue Biopsy
    Others

Market segment by Application
    Hospitals
    Clinics
    Medical Research Centers
    Academic Institutes
    Others

Market segment by players, this report covers
    FUJIFILM Holdings Corporation
    GE Healthcare
    Koninklijke Philips N.V.
    Pluristem Therapeutics Inc.
    Shimadzu Corporation
    Siemens Healthcare GmbH
    Stempeutics Research Pvt. Ltd.
    Canon Medical Systems Corporation
    t2cure GmbH

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Buerger Disease Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Buerger Disease Diagnosis, with revenue, gross margin and global market share of Buerger Disease Diagnosis from 2019 to 2024.
Chapter 3, the Buerger Disease Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Buerger Disease Diagnosis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Buerger Disease Diagnosis.
Chapter 13, to describe Buerger Disease Diagnosis research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Buerger Disease Diagnosis
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Buerger Disease Diagnosis by Type
        1.3.1 Overview: Global Buerger Disease Diagnosis Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Buerger Disease Diagnosis Consumption Value Market Share by Type in 2023
        1.3.3 Blood Tests
        1.3.4 The Allen’s Test
        1.3.5 Angiogram
        1.3.6 Tissue Biopsy
        1.3.7 Others
    1.4 Global Buerger Disease Diagnosis Market by Application
        1.4.1 Overview: Global Buerger Disease Diagnosis Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Medical Research Centers
        1.4.5 Academic Institutes
        1.4.6 Others
    1.5 Global Buerger Disease Diagnosis Market Size & Forecast
    1.6 Global Buerger Disease Diagnosis Market Size and Forecast by Region
        1.6.1 Global Buerger Disease Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Buerger Disease Diagnosis Market Size by Region, (2019-2030)
        1.6.3 North America Buerger Disease Diagnosis Market Size and Prospect (2019-2030)
        1.6.4 Europe Buerger Disease Diagnosis Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Buerger Disease Diagnosis Market Size and Prospect (2019-2030)
        1.6.6 South America Buerger Disease Diagnosis Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Buerger Disease Diagnosis Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 FUJIFILM Holdings Corporation
        2.1.1 FUJIFILM Holdings Corporation Details
        2.1.2 FUJIFILM Holdings Corporation Major Business
        2.1.3 FUJIFILM Holdings Corporation Buerger Disease Diagnosis Product and Solutions
        2.1.4 FUJIFILM Holdings Corporation Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 FUJIFILM Holdings Corporation Recent Developments and Future Plans
    2.2 GE Healthcare
        2.2.1 GE Healthcare Details
        2.2.2 GE Healthcare Major Business
        2.2.3 GE Healthcare Buerger Disease Diagnosis Product and Solutions
        2.2.4 GE Healthcare Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GE Healthcare Recent Developments and Future Plans
    2.3 Koninklijke Philips N.V.
        2.3.1 Koninklijke Philips N.V. Details
        2.3.2 Koninklijke Philips N.V. Major Business
        2.3.3 Koninklijke Philips N.V. Buerger Disease Diagnosis Product and Solutions
        2.3.4 Koninklijke Philips N.V. Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Koninklijke Philips N.V. Recent Developments and Future Plans
    2.4 Pluristem Therapeutics Inc.
        2.4.1 Pluristem Therapeutics Inc. Details
        2.4.2 Pluristem Therapeutics Inc. Major Business
        2.4.3 Pluristem Therapeutics Inc. Buerger Disease Diagnosis Product and Solutions
        2.4.4 Pluristem Therapeutics Inc. Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Pluristem Therapeutics Inc. Recent Developments and Future Plans
    2.5 Shimadzu Corporation
        2.5.1 Shimadzu Corporation Details
        2.5.2 Shimadzu Corporation Major Business
        2.5.3 Shimadzu Corporation Buerger Disease Diagnosis Product and Solutions
        2.5.4 Shimadzu Corporation Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Shimadzu Corporation Recent Developments and Future Plans
    2.6 Siemens Healthcare GmbH
        2.6.1 Siemens Healthcare GmbH Details
        2.6.2 Siemens Healthcare GmbH Major Business
        2.6.3 Siemens Healthcare GmbH Buerger Disease Diagnosis Product and Solutions
        2.6.4 Siemens Healthcare GmbH Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Siemens Healthcare GmbH Recent Developments and Future Plans
    2.7 Stempeutics Research Pvt. Ltd.
        2.7.1 Stempeutics Research Pvt. Ltd. Details
        2.7.2 Stempeutics Research Pvt. Ltd. Major Business
        2.7.3 Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Product and Solutions
        2.7.4 Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Stempeutics Research Pvt. Ltd. Recent Developments and Future Plans
    2.8 Canon Medical Systems Corporation
        2.8.1 Canon Medical Systems Corporation Details
        2.8.2 Canon Medical Systems Corporation Major Business
        2.8.3 Canon Medical Systems Corporation Buerger Disease Diagnosis Product and Solutions
        2.8.4 Canon Medical Systems Corporation Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Canon Medical Systems Corporation Recent Developments and Future Plans
    2.9 t2cure GmbH
        2.9.1 t2cure GmbH Details
        2.9.2 t2cure GmbH Major Business
        2.9.3 t2cure GmbH Buerger Disease Diagnosis Product and Solutions
        2.9.4 t2cure GmbH Buerger Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 t2cure GmbH Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Buerger Disease Diagnosis Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Buerger Disease Diagnosis by Company Revenue
        3.2.2 Top 3 Buerger Disease Diagnosis Players Market Share in 2023
        3.2.3 Top 6 Buerger Disease Diagnosis Players Market Share in 2023
    3.3 Buerger Disease Diagnosis Market: Overall Company Footprint Analysis
        3.3.1 Buerger Disease Diagnosis Market: Region Footprint
        3.3.2 Buerger Disease Diagnosis Market: Company Product Type Footprint
        3.3.3 Buerger Disease Diagnosis Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Buerger Disease Diagnosis Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Buerger Disease Diagnosis Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2024)
    5.2 Global Buerger Disease Diagnosis Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Buerger Disease Diagnosis Consumption Value by Type (2019-2030)
    6.2 North America Buerger Disease Diagnosis Consumption Value by Application (2019-2030)
    6.3 North America Buerger Disease Diagnosis Market Size by Country
        6.3.1 North America Buerger Disease Diagnosis Consumption Value by Country (2019-2030)
        6.3.2 United States Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        6.3.3 Canada Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        6.3.4 Mexico Buerger Disease Diagnosis Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Buerger Disease Diagnosis Consumption Value by Type (2019-2030)
    7.2 Europe Buerger Disease Diagnosis Consumption Value by Application (2019-2030)
    7.3 Europe Buerger Disease Diagnosis Market Size by Country
        7.3.1 Europe Buerger Disease Diagnosis Consumption Value by Country (2019-2030)
        7.3.2 Germany Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        7.3.3 France Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        7.3.5 Russia Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        7.3.6 Italy Buerger Disease Diagnosis Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Buerger Disease Diagnosis Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Buerger Disease Diagnosis Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Buerger Disease Diagnosis Market Size by Region
        8.3.1 Asia-Pacific Buerger Disease Diagnosis Consumption Value by Region (2019-2030)
        8.3.2 China Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        8.3.3 Japan Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        8.3.4 South Korea Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        8.3.5 India Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        8.3.7 Australia Buerger Disease Diagnosis Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Buerger Disease Diagnosis Consumption Value by Type (2019-2030)
    9.2 South America Buerger Disease Diagnosis Consumption Value by Application (2019-2030)
    9.3 South America Buerger Disease Diagnosis Market Size by Country
        9.3.1 South America Buerger Disease Diagnosis Consumption Value by Country (2019-2030)
        9.3.2 Brazil Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        9.3.3 Argentina Buerger Disease Diagnosis Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Buerger Disease Diagnosis Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Buerger Disease Diagnosis Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Buerger Disease Diagnosis Market Size by Country
        10.3.1 Middle East & Africa Buerger Disease Diagnosis Consumption Value by Country (2019-2030)
        10.3.2 Turkey Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Buerger Disease Diagnosis Market Size and Forecast (2019-2030)
        10.3.4 UAE Buerger Disease Diagnosis Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Buerger Disease Diagnosis Market Drivers
    11.2 Buerger Disease Diagnosis Market Restraints
    11.3 Buerger Disease Diagnosis Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Buerger Disease Diagnosis Industry Chain
    12.2 Buerger Disease Diagnosis Upstream Analysis
    12.3 Buerger Disease Diagnosis Midstream Analysis
    12.4 Buerger Disease Diagnosis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Buerger Disease Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Buerger Disease Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Buerger Disease Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Buerger Disease Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. FUJIFILM Holdings Corporation Company Information, Head Office, and Major Competitors
    Table 6. FUJIFILM Holdings Corporation Major Business
    Table 7. FUJIFILM Holdings Corporation Buerger Disease Diagnosis Product and Solutions
    Table 8. FUJIFILM Holdings Corporation Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. FUJIFILM Holdings Corporation Recent Developments and Future Plans
    Table 10. GE Healthcare Company Information, Head Office, and Major Competitors
    Table 11. GE Healthcare Major Business
    Table 12. GE Healthcare Buerger Disease Diagnosis Product and Solutions
    Table 13. GE Healthcare Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. GE Healthcare Recent Developments and Future Plans
    Table 15. Koninklijke Philips N.V. Company Information, Head Office, and Major Competitors
    Table 16. Koninklijke Philips N.V. Major Business
    Table 17. Koninklijke Philips N.V. Buerger Disease Diagnosis Product and Solutions
    Table 18. Koninklijke Philips N.V. Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Koninklijke Philips N.V. Recent Developments and Future Plans
    Table 20. Pluristem Therapeutics Inc. Company Information, Head Office, and Major Competitors
    Table 21. Pluristem Therapeutics Inc. Major Business
    Table 22. Pluristem Therapeutics Inc. Buerger Disease Diagnosis Product and Solutions
    Table 23. Pluristem Therapeutics Inc. Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Pluristem Therapeutics Inc. Recent Developments and Future Plans
    Table 25. Shimadzu Corporation Company Information, Head Office, and Major Competitors
    Table 26. Shimadzu Corporation Major Business
    Table 27. Shimadzu Corporation Buerger Disease Diagnosis Product and Solutions
    Table 28. Shimadzu Corporation Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Shimadzu Corporation Recent Developments and Future Plans
    Table 30. Siemens Healthcare GmbH Company Information, Head Office, and Major Competitors
    Table 31. Siemens Healthcare GmbH Major Business
    Table 32. Siemens Healthcare GmbH Buerger Disease Diagnosis Product and Solutions
    Table 33. Siemens Healthcare GmbH Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Siemens Healthcare GmbH Recent Developments and Future Plans
    Table 35. Stempeutics Research Pvt. Ltd. Company Information, Head Office, and Major Competitors
    Table 36. Stempeutics Research Pvt. Ltd. Major Business
    Table 37. Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Product and Solutions
    Table 38. Stempeutics Research Pvt. Ltd. Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Stempeutics Research Pvt. Ltd. Recent Developments and Future Plans
    Table 40. Canon Medical Systems Corporation Company Information, Head Office, and Major Competitors
    Table 41. Canon Medical Systems Corporation Major Business
    Table 42. Canon Medical Systems Corporation Buerger Disease Diagnosis Product and Solutions
    Table 43. Canon Medical Systems Corporation Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Canon Medical Systems Corporation Recent Developments and Future Plans
    Table 45. t2cure GmbH Company Information, Head Office, and Major Competitors
    Table 46. t2cure GmbH Major Business
    Table 47. t2cure GmbH Buerger Disease Diagnosis Product and Solutions
    Table 48. t2cure GmbH Buerger Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. t2cure GmbH Recent Developments and Future Plans
    Table 50. Global Buerger Disease Diagnosis Revenue (USD Million) by Players (2019-2024)
    Table 51. Global Buerger Disease Diagnosis Revenue Share by Players (2019-2024)
    Table 52. Breakdown of Buerger Disease Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Buerger Disease Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 54. Head Office of Key Buerger Disease Diagnosis Players
    Table 55. Buerger Disease Diagnosis Market: Company Product Type Footprint
    Table 56. Buerger Disease Diagnosis Market: Company Product Application Footprint
    Table 57. Buerger Disease Diagnosis New Market Entrants and Barriers to Market Entry
    Table 58. Buerger Disease Diagnosis Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Buerger Disease Diagnosis Consumption Value (USD Million) by Type (2019-2024)
    Table 60. Global Buerger Disease Diagnosis Consumption Value Share by Type (2019-2024)
    Table 61. Global Buerger Disease Diagnosis Consumption Value Forecast by Type (2025-2030)
    Table 62. Global Buerger Disease Diagnosis Consumption Value by Application (2019-2024)
    Table 63. Global Buerger Disease Diagnosis Consumption Value Forecast by Application (2025-2030)
    Table 64. North America Buerger Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
    Table 65. North America Buerger Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
    Table 66. North America Buerger Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. North America Buerger Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. North America Buerger Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
    Table 69. North America Buerger Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
    Table 70. Europe Buerger Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Europe Buerger Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Europe Buerger Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
    Table 73. Europe Buerger Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
    Table 74. Europe Buerger Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Buerger Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
    Table 77. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
    Table 78. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
    Table 79. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
    Table 80. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
    Table 81. Asia-Pacific Buerger Disease Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
    Table 82. South America Buerger Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
    Table 83. South America Buerger Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
    Table 84. South America Buerger Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
    Table 85. South America Buerger Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
    Table 86. South America Buerger Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. South America Buerger Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
    Table 89. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
    Table 90. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
    Table 91. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
    Table 93. Middle East & Africa Buerger Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
    Table 94. Buerger Disease Diagnosis Raw Material
    Table 95. Key Suppliers of Buerger Disease Diagnosis Raw Materials
List of Figures
    Figure 1. Buerger Disease Diagnosis Picture
    Figure 2. Global Buerger Disease Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Buerger Disease Diagnosis Consumption Value Market Share by Type in 2023
    Figure 4. Blood Tests
    Figure 5. The Allen’s Test
    Figure 6. Angiogram
    Figure 7. Tissue Biopsy
    Figure 8. Others
    Figure 9. Global Buerger Disease Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Buerger Disease Diagnosis Consumption Value Market Share by Application in 2023
    Figure 11. Hospitals Picture
    Figure 12. Clinics Picture
    Figure 13. Medical Research Centers Picture
    Figure 14. Academic Institutes Picture
    Figure 15. Others Picture
    Figure 16. Global Buerger Disease Diagnosis Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 17. Global Buerger Disease Diagnosis Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 18. Global Market Buerger Disease Diagnosis Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 19. Global Buerger Disease Diagnosis Consumption Value Market Share by Region (2019-2030)
    Figure 20. Global Buerger Disease Diagnosis Consumption Value Market Share by Region in 2023
    Figure 21. North America Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East and Africa Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Buerger Disease Diagnosis Revenue Share by Players in 2023
    Figure 27. Buerger Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 28. Global Top 3 Players Buerger Disease Diagnosis Market Share in 2023
    Figure 29. Global Top 6 Players Buerger Disease Diagnosis Market Share in 2023
    Figure 30. Global Buerger Disease Diagnosis Consumption Value Share by Type (2019-2024)
    Figure 31. Global Buerger Disease Diagnosis Market Share Forecast by Type (2025-2030)
    Figure 32. Global Buerger Disease Diagnosis Consumption Value Share by Application (2019-2024)
    Figure 33. Global Buerger Disease Diagnosis Market Share Forecast by Application (2025-2030)
    Figure 34. North America Buerger Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
    Figure 35. North America Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
    Figure 36. North America Buerger Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 38. Canada Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 39. Mexico Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 40. Europe Buerger Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
    Figure 41. Europe Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
    Figure 42. Europe Buerger Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 44. France Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 45. United Kingdom Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 46. Russia Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 47. Italy Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Buerger Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Buerger Disease Diagnosis Consumption Value Market Share by Region (2019-2030)
    Figure 51. China Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 52. Japan Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 53. South Korea Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 54. India Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 55. Southeast Asia Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 56. Australia Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 57. South America Buerger Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
    Figure 58. South America Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
    Figure 59. South America Buerger Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
    Figure 60. Brazil Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 61. Argentina Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 62. Middle East and Africa Buerger Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
    Figure 63. Middle East and Africa Buerger Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
    Figure 64. Middle East and Africa Buerger Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
    Figure 65. Turkey Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 66. Saudi Arabia Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 67. UAE Buerger Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
    Figure 68. Buerger Disease Diagnosis Market Drivers
    Figure 69. Buerger Disease Diagnosis Market Restraints
    Figure 70. Buerger Disease Diagnosis Market Trends
    Figure 71. Porters Five Forces Analysis
    Figure 72. Manufacturing Cost Structure Analysis of Buerger Disease Diagnosis in 2023
    Figure 73. Manufacturing Process Analysis of Buerger Disease Diagnosis
    Figure 74. Buerger Disease Diagnosis Industrial Chain
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Companies Mentioned

FUJIFILM Holdings Corporation
GE Healthcare
Koninklijke Philips N.V.
Pluristem Therapeutics Inc.
Shimadzu Corporation
Siemens Healthcare GmbH
Stempeutics Research Pvt. Ltd.
Canon Medical Systems Corporation
t2cure GmbH